Navigation Links
Silence Therapeutics Issued New Patents Covering siRNA Sequences for RNA Interference Therapeutics
Date:9/8/2010

LONDON, Sept. 8 /PRNewswire/ -- Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company") announces the issuance of two new patents by the United States Patent and Trademark Office (USPTO) which are broadly directed to double-stranded short interfering RNA (siRNA) sequences against the validated cancer targets epidermal growth factor receptor related protein (EGFR-RP) and vascular endothelial growth factor receptor 1 (VEGFR1).  EGFR-RP and VEGFR1 have been demonstrated to play key roles in the underlying causes of various cancers including abnormal angiogenesis and uncontrolled cell division.  Similar to vascular endothelial growth factor receptor 2 (VEGFR2), VEGFR1 also is implicated in the development and progression of age-related macular degeneration (AMD) and other serious ocular diseases.  The EGFR-RP patent is broadly directed to methods of reducing EGFR-RP with a DNA or RNA molecule, including siRNA molecules.  The sequence covered by the VEGFR1 patent is a potent 25mer siRNA, demonstrating Silence's continued ability to secure meaningful intellectual property protection for its portfolio of 25mer sequences.

"The past several months have seen Silence add a number of high-value patents to its broad RNAi intellectual property portfolio.  Whereas many of these recent issuances have focused on the structural modification of RNAi therapeutics to improve efficacy, today's announcement underscores our efforts to concurrently build critical protection in the equally important areas of siRNA sequences and siRNA delivery," said Philip Haworth, Ph.D., chief executive officer of Silence Therapeutics.  "We are particularly pleased that we have been able to secure an additional patent covering 25mer siRNA sequences, validating our belief that we can build a portfolio of proprietary 25mer siRNA sequences that will provide us an added level of protection in the RNAi space.  Furthermore, the breadth of the issued EGFR-RP pa
'/>"/>

SOURCE Silence Therapeutics plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Silence Therapeutics and AstraZeneca Extend siRNA Development Collaboration
2. Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company
3. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
4. Silence Therapeutics Announces Board Changes
5. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
6. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
7. Actress and New Mom Keri Russell Joins PKIDs to launch Silence the Sounds of Pertussis Campaign
8. Precision Therapeutics, Inc. Named to Pittsburgh Business Times 2010 Top 100
9. Orexigen® Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave® in North America
10. Reportlinker Adds Urological Disorders Therapeutics to 2016 - Increasing Awareness and Aging Population will Drive the Benign Prostatic Hyperplasia and Urinary Incontinence Markets
11. Orexigen(R) Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), announced that the ... Lixte,s lead compound, LB‑100, is being conducted, has been expanded ... Kovach , M.D., the founder and President of Lixte, said ... a single site. Accrual of patients, however, was slower than ...
(Date:1/23/2015)... , Jan. 23, 2015   Leatt Corporation  (OTCQB: LEAT), ... equipment for all forms of sports, including extreme motor ... brace, announced today that the UISP Lega Motociclismo Lombardia, ... all riders to wear a neck brace during its ...
(Date:1/23/2015)... , Jan. 23, 2015  Mallinckrodt plc (NYSE: ... has approved a share repurchase program. The open-ended authorization ... of Mallinckrodt plc ordinary shares. "Funding ... top priorities as we continue to pursue a range ...
Breaking Medicine Technology:Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 3Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4
... Jan. 19, 2012  CutisPharma, Inc. announced the introduction ... Unit-of-Use oral suspension compounding kits. These new kits ... widely used proton pump inhibitors (PPIs). Traditionally, compounded ... to several hours to prepare and are quite ...
... Patients with hip and knee replacements can now ... their body thanks to a new tracking system being ... Sporer and Wayne Paprosky, MOR hip and knee orthopaedic ... all compliant patients with radiostereometric analysis (RSA) beads, which ...
Cached Medicine Technology:CutisPharma Expands Product Line with New Oral Suspension Prescription Compounding Kits 2New Technology to Track Movement and Durability of Implants in Hip and Knee Replacement Patients 2New Technology to Track Movement and Durability of Implants in Hip and Knee Replacement Patients 3
(Date:1/22/2015)... 2015 Gabe’s Chemo Duck Program is pleased to ... app ever created for kids with cancer. The Chemo Duck App, ... is filled with enjoyable games to help children of all ages ... app helps to keep kids entertained, educated and at ease while ...
(Date:1/22/2015)... a famous wedding dress company offering many trendy designs. Today, ... Twitter, and Pinterest. The fans will have an opportunity to ... week. , Moreover, the company has extended its 2015 New ... for more information. , Angelweddingdress is a famous ...
(Date:1/22/2015)... 2015 Juvent Sports ( http://www.juventsports.com ) ... PGA Merchandise Show to bestow a Juvent Sports Achievement ... golfer, Arlene McKitrick. The award commemorated and congratulated McKitrick ... win. She won her first amateur tournament in 1979 ...
(Date:1/22/2015)... over 20 years, Dr. David Cruz of Cruz Chiropractic Care ... just about every type of injury that can result from car ... twenty-plus years, the team at Doctors on Liens has ... doctor. With the combined breadth of experience between the ...
(Date:1/22/2015)... La Jolla, Calif. (PRWEB) January 22, 2015 ... and Assemblymembers Susan Bonilla (D-Concord) and Kristin Olsen ... (CHI) for their leadership in advancing biotechnology, biomedical ... Mitchell, Bonilla and Olsen each received the “2014 ...
Breaking Medicine News(10 mins):Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3
... recommended for breast cancer patients, who show positive for ... is positive, and they have a more resistant and ... women are Her-2/neu positive and the treatment for these ... does not show any significant disease reduction. These patients ...
... common forms of dementia among older people, which initially involves ... memory, and language. // , ,Researchers from USA have ... and have speculated about their use as preventive agents. The ... the RDA (400 ìg/d) is associated with a reduced risk ...
... Lausanne) and the CHUV (Lausanne University Hospital) have discovered ... the true multipotent stem cell category and can // ... and follicle replacement. , ,The research team has ... the October 3 issue of Proceedings of the National ...
... India has always been looked at by outsiders as the ... harmonious central key to getting in touch with the spiritual ... large sub-continent then what meets the eye at first glance ... ,Tourism has been a thriving business in India for ...
... for a long and healthy life has been known for ... can cause dangerous interactions when taken along with medicines. Foods ... orally administered drugs. The effect does not hold good for ... or well documented of these effects is the one involving ...
... that 36 million deaths occurs world wide due to chronic ... serious measures has to be taken to prevent this // ... responsible for the cause of the diseases is Tobacco, poor ... fats and sugars, doing less activity due to work and ...
Cached Medicine News:
...
...
...
Rhoton Curettes, titanium, length 191 mm, straight....
Medicine Products: